- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
News Briefs: Data Critical/Elixis merger extends wireless capabilities
Data Critical/Elixis merger extends wireless capabilitiesPursuing its goal of creating a wireless, Web-based clinical information system, Data Critical has agreed to buy Elixis, a privately held company that offers Web-based applications to access
Data Critical/Elixis merger extends wireless capabilities
Pursuing its goal of creating a wireless, Web-based clinical information system, Data Critical has agreed to buy Elixis, a privately held company that offers Web-based applications to access patient information and to automate repetitive tasks like coding and letter and prescription writing. Terms of the deal have yet to be disclosed.
This latest purchase closely follows Data Criticals acquisition of Physix, a provider of mobile handheld workflow applications, for approximately $4.9 million in December 1999. Elixis will become part of a Data Critical subsidiary and will continue its existing distribution partnerships with Baxter Healthcare and Boston Scientific and its strategic alliances with drugstore.com, CVS.com, Physicians Online, MD Consult, and Healthstream.
© 2000 Miller Freeman, Inc., a United News & Media company.
- Search again
- Homepage
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
